809 related articles for article (PubMed ID: 21497925)
1. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
[TBL] [Abstract][Full Text] [Related]
2. Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.
Galldiks N; Langen KJ; Holy R; Pinkawa M; Stoffels G; Nolte KW; Kaiser HJ; Filss CP; Fink GR; Coenen HH; Eble MJ; Piroth MD
J Nucl Med; 2012 Jul; 53(7):1048-57. PubMed ID: 22645298
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
Piroth MD; Pinkawa M; Holy R; Klotz J; Nussen S; Stoffels G; Coenen HH; Kaiser HJ; Langen KJ; Eble MJ
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):176-84. PubMed ID: 20646863
[TBL] [Abstract][Full Text] [Related]
4. Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.
Suchorska B; Jansen NL; Linn J; Kretzschmar H; Janssen H; Eigenbrod S; Simon M; Pöpperl G; Kreth FW; la Fougere C; Weller M; Tonn JC;
Neurology; 2015 Feb; 84(7):710-9. PubMed ID: 25609769
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful?
Piroth MD; Liebenstund S; Galldiks N; Stoffels G; Shah NJ; Eble MJ; Coenen HH; Langen KJ
Mol Imaging; 2013 Sep; 12(6):388-95. PubMed ID: 23981784
[TBL] [Abstract][Full Text] [Related]
6. (18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.
Buchmann N; Kläsner B; Gempt J; Bauer JS; Pyka T; Delbridge C; Meyer B; Krause BJ; Ringel F
World Neurosurg; 2016 May; 89():420-6. PubMed ID: 26893043
[TBL] [Abstract][Full Text] [Related]
7. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
8. O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
Sweeney R; Polat B; Samnick S; Reiners C; Flentje M; Verburg FA
Ann Nucl Med; 2014 Feb; 28(2):154-62. PubMed ID: 24272067
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of subventricular zone involvement in relation to tumor volumes defined by fused MRI and O-(2-[
Harat M; Małkowski B; Roszkowski K
Radiat Oncol; 2019 Mar; 14(1):37. PubMed ID: 30832691
[TBL] [Abstract][Full Text] [Related]
11. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
12. Can Early Postoperative O-(2-
Buchmann N; Gempt J; Ryang YM; Pyka T; Kirschke JS; Meyer B; Ringel F
World Neurosurg; 2019 Jan; 121():e467-e474. PubMed ID: 30267942
[TBL] [Abstract][Full Text] [Related]
13. Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.
Piroth MD; Galldiks N; Pinkawa M; Holy R; Stoffels G; Ermert J; Mottaghy FM; Shah NJ; Langen KJ; Eble MJ
Radiat Oncol; 2016 Jun; 11():87. PubMed ID: 27342976
[TBL] [Abstract][Full Text] [Related]
14. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.
Galldiks N; Dunkl V; Stoffels G; Hutterer M; Rapp M; Sabel M; Reifenberger G; Kebir S; Dorn F; Blau T; Herrlinger U; Hau P; Ruge MI; Kocher M; Goldbrunner R; Fink GR; Drzezga A; Schmidt M; Langen KJ
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):685-95. PubMed ID: 25411133
[TBL] [Abstract][Full Text] [Related]
16. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ
J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolevulinic Acid Fluorescence-Guided Resection of 18F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma.
Müther M; Koch R; Weckesser M; Sporns P; Schwindt W; Stummer W
Neurosurgery; 2019 Dec; 85(6):E1020-E1029. PubMed ID: 31215632
[TBL] [Abstract][Full Text] [Related]
18. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
19. Static FET-PET and MR Imaging in Anaplastic Gliomas (WHO III).
Bette S; Peschke P; Kaesmacher J; Delbridge C; Pyka T; Schmidt-Graf F; Zimmer C; Meyer B; Ringel F; Gempt J
World Neurosurg; 2016 Jul; 91():524-531.e1. PubMed ID: 26947726
[TBL] [Abstract][Full Text] [Related]
20. Dissociation Between 11C-Methionine-Positron Emission Tomography and Gadolinium-Enhanced Magnetic Resonance Imaging in Longitudinal Features of Glioblastoma After Postoperative Radiotherapy.
Kawasaki T; Miwa K; Shinoda J; Asano Y; Takei H; Ikegame Y; Yokoyama K; Yano H; Iwama T
World Neurosurg; 2019 May; 125():93-100. PubMed ID: 30716494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]